NEPHROS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
NEPHROS, INC. (NEPH) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$229.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2014-11-13
- NEPHROS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-09-30 was -$49.00K, a 118.08% decline year-over-year.
- NEPHROS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-06-30 was $47.00K.
- NEPHROS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-03-31 was -$227.00K.
- NEPHROS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-12-31 was $104.00K, a 83.17% decline year-over-year.
- NEPHROS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2013 was $59.00K, a 93.47% decline from fiscal 2012.
- NEPHROS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was $904.00K.
- NEPHROS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was -$357.00K, a 308.77% decline from fiscal 2010.
- NEPHROS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2010 was $171.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2014-09-30 | -$49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$2.00K derived: sum of 2 quarters · filed 2014-11-13 | -$229.00K 10-Q · filed 2014-11-13 | -$125.00K derived: sum of 4 quarters · filed 2014-11-13 | |
| 2014-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$180.00K 10-Q · filed 2014-08-14 | -$76.00K derived: sum of 3 quarters · filed 2014-08-14 | $195.00K derived: sum of 4 quarters · filed 2014-11-13 | |
| 2014-03-31 | -$227.00K 10-Q · filed 2014-05-14 | -$123.00K derived: sum of 2 quarters · filed 2014-05-14 | $148.00K derived: sum of 3 quarters · filed 2014-11-13 | -$137.00K derived: sum of 4 quarters · filed 2014-11-13 | |
| 2013-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $375.00K derived: sum of 2 quarters · filed 2014-11-13 | $90.00K derived: sum of 3 quarters · filed 2014-11-13 | $59.00K 10-K · filed 2014-03-28 | |
| 2013-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$14.00K derived: sum of 2 quarters · filed 2014-11-13 | -$45.00K 10-Q · filed 2014-11-13 | $573.00K derived: sum of 4 quarters · filed 2014-11-13 | |
| 2013-06-30 | -$285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$316.00K 10-Q · filed 2014-08-14 | -$330.00K 10-Q · filed 2013-08-13 | $302.00K derived: sum of 3 quarters · filed 2014-08-14 | $530.00K derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | -$31.00K 10-Q · filed 2014-05-14 | $587.00K derived: sum of 2 quarters · filed 2014-05-14 | $815.00K derived: sum of 3 quarters · filed 2014-05-14 | $711.00K derived: sum of 4 quarters · filed 2014-05-14 | |
| 2012-12-31 | $618.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $846.00K derived: sum of 2 quarters · filed 2014-03-28 | $742.00K derived: sum of 3 quarters · filed 2014-03-28 | $904.00K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $124.00K derived: sum of 2 quarters · filed 2013-11-14 | $286.00K 10-Q · filed 2013-11-14 | $235.00K derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | -$104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $58.00K 10-Q · filed 2013-08-13 | $7.00K derived: sum of 3 quarters · filed 2013-08-13 | -$25.00K derived: sum of 4 quarters · filed 2013-08-13 | |
| 2012-03-31 | $162.00K 10-Q · filed 2013-05-08 | $111.00K derived: sum of 2 quarters · filed 2013-05-08 | $79.00K derived: sum of 3 quarters · filed 2013-05-08 | -$202.00K derived: sum of 4 quarters · filed 2013-05-08 | |
| 2011-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-04 | -$83.00K derived: sum of 2 quarters · filed 2013-03-04 | -$364.00K derived: sum of 3 quarters · filed 2013-03-04 | -$357.00K 10-K · filed 2013-03-04 | |
| 2011-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$313.00K derived: sum of 2 quarters · filed 2012-11-09 | -$306.00K 10-Q · filed 2012-11-09 | -$264.00K derived: sum of 4 quarters · filed 2012-11-09 | |
| 2011-06-30 | -$281.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$274.00K 10-Q · filed 2012-08-14 | -$232.00K derived: sum of 3 quarters · filed 2012-08-14 | -$295.00K derived: sum of 4 quarters · filed 2012-08-14 | |
| 2011-03-31 | $7.00K 10-Q · filed 2012-05-15 | $49.00K derived: sum of 2 quarters · filed 2012-05-15 | -$14.00K derived: sum of 3 quarters · filed 2012-05-15 | ||
| 2010-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | -$21.00K derived: sum of 2 quarters · filed 2012-03-22 | $171.00K 10-K · filed 2012-03-22 | ||
| 2010-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $129.00K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $192.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |